12:00 AM
 | 
Oct 08, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ceftobiprole regulatory update

Basilea said an MAA for pneumonia product ceftobiprole was accepted for review under Europe's...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >